Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells

Glioblastoma (GBM) is the most aggressive and malignant brain tumor, resulting in a poor prognosis. The current therapy for GBM consists in concurrent radiation and chemotherapy following removal of the tumor. Although the therapy prolongs patient survival, recurrence often occurs. The major cause o...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Min Gi, Seo, Sunyoung, Ham, Seok Won, Choi, Sang-Hun, Kim, Hyunggee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377049/
https://www.ncbi.nlm.nih.gov/pubmed/32724355
http://dx.doi.org/10.3892/ol.2020.11668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377049/
https://www.ncbi.nlm.nih.gov/pubmed/32724355
http://dx.doi.org/10.3892/ol.2020.11668

Ejemplares similares